ResearchSafe

Follistatin 344 (Follistatin 344 (FST-344))

Category: Muscle Growth. Status: Research compound.

A naturally occurring glycoprotein that binds and neutralizes myostatin and activin. The longest isoform enabling significant muscle hypertrophy by removing growth inhibitors.

How it works

Binds myostatin and activin A with high affinity, preventing ActRIIB receptor activation. Removes the brake on muscle growth allowing uninhibited satellite cell proliferation.

Key facts

  • Molecular weight: 36,000 Da
  • Half-life: 2-4 hours
  • Bioavailability: Moderate (SubQ)
  • Storage: Lyophilized: -20°C. Reconstituted: 2-8°C for 7 days.

Dosing overview

  • Typical dose: 100-200 mcg
  • Frequency: Daily for 10-30 days
  • Duration: 10-30 day protocols
  • Route: Subcutaneous

Reported benefits

  • Significant muscle growth
  • Myostatin inhibition
  • Increased strength
  • Activin neutralization
  • Enhanced recovery

Possible side effects

  • Limited safety data
  • Theoretical reproductive effects
  • Joint stress from rapid gains
  • Cardiac muscle effects (theoretical)

Research

  • Follistatin gene therapy for muscle wasting (2022): AAV-delivered FST-344 increased quadriceps volume by 15% in Becker MD patients.
  • Myostatin inhibition by follistatin in primates (2020): Increased lean muscle by 20% without significant off-target effects over 8 weeks.

Compare Follistatin 344

Community discussions about Follistatin 344

Research and educational reference only. Not medical advice.